Kähäri VM - Search Results

1

Matrix metalloproteinases in inflammation.

Nissinen L, Kähäri VM. Nissinen L, et al. Among authors: kahari vm. Biochim Biophys Acta. 2014 Aug;1840(8):2571-80. doi: 10.1016/j.bbagen.2014.03.007. Epub 2014 Mar 14. Biochim Biophys Acta. 2014. PMID: 24631662 Review.

2

Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kähäri VM, Heino J. Ivaska J, et al. Among authors: kahari vm. Mol Cell Biol. 2002 Mar;22(5):1352-9. doi: 10.1128/MCB.22.5.1352-1359.2002. Mol Cell Biol. 2002. PMID: 11839802 Free PMC article.

3

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Vihinen P, Kähäri VM. Vihinen P, et al. Among authors: kahari vm. Int J Cancer. 2002 May 10;99(2):157-66. doi: 10.1002/ijc.10329. Int J Cancer. 2002. PMID: 11979428 Free article. Review.

4

Endothelial cell-matrix interactions.

Iivanainen E, Kähäri VM, Heino J, Elenius K. Iivanainen E, et al. Among authors: kahari vm. Microsc Res Tech. 2003 Jan 1;60(1):13-22. doi: 10.1002/jemt.10238. Microsc Res Tech. 2003. PMID: 12500256 Review.

5

Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.

Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kähäri VM, Saarialho-Kere U. Impola U, et al. Among authors: kahari vm. Int J Cancer. 2003 Mar 1;103(6):709-16. doi: 10.1002/ijc.10902. Int J Cancer. 2003. PMID: 12516088 Free article.

6

Matrix metalloproteinases as therapeutic targets in cancer.

Vihinen P, Ala-aho R, Kähäri VM. Vihinen P, et al. Among authors: kahari vm. Curr Cancer Drug Targets. 2005 May;5(3):203-20. doi: 10.2174/1568009053765799. Curr Cancer Drug Targets. 2005. PMID: 15892620 Review.

7

Temporospatial expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mouse antigen-induced arthritis.

Joronen K, Kähäri VM, Vuorio E. Joronen K, et al. Among authors: kahari vm. Histochem Cell Biol. 2005 Dec;124(6):535-45. doi: 10.1007/s00418-005-0011-2. Epub 2005 Aug 27. Histochem Cell Biol. 2005. PMID: 16133125

8

Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.

Luukkaa H, Klemi P, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM, Grénman R. Luukkaa H, et al. Among authors: kahari vm. Acta Otolaryngol. 2008 Apr;128(4):482-90. doi: 10.1080/00016480801922895. Acta Otolaryngol. 2008. PMID: 18368586

9

Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer.

Luukkaa H, Klemi P, Leivo I, Mäkitie AA, Irish J, Gilbert R, Perez-Ordonez B, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM, Grénman R. Luukkaa H, et al. Among authors: kahari vm. Head Neck. 2010 Aug;32(8):1019-27. doi: 10.1002/hed.21277. Head Neck. 2010. PMID: 19902536

10

ADAMTS5: A New Player in the Vascular Field.

Nissinen L, Kähäri VM. Nissinen L, et al. Among authors: kahari vm. Am J Pathol. 2012 Sep;181(3):743-5. doi: 10.1016/j.ajpath.2012.07.002. Epub 2012 Jul 20. Am J Pathol. 2012. PMID: 22824241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page